Skip to content

Released Oct 30, 2017, after the close

10-Q filed Oct 30, 2017, 30 days after period end · 0001564590-17-020382

Q3 2017 · 10-Q
Revenue$105.25M+6.9% vs Q3 2016−3.4% vs Q2 2017
Net Income$3.46M−65.1% vs Q3 2016−10.3% vs Q2 2017
EPS Diluted$0.19−64.8% vs Q3 2016−9.5% vs Q2 2017
Gross Profit$81,530,000+3.7%
Operating Income$9,034,000−2.6%
Operating Cash Flowderived$13,767,000−19.1%
Free Cash Flowderived$9,361,000−31.6%
Margins · derived
Gross margin77.5%−2.4 pt vs Q3 2016
Operating margin8.6%−0.8 pt vs Q3 2016
Net margin3.3%−6.8 pt vs Q3 2016

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ3 2017Q3 2016Q3 2015Q3 2014
Revenue$105.25M$98.50M$101.15M$100.99M
Net Income$3.46M$9.90M-$1.37M$452.00K
EPS Diluted$0.19$0.54-$0.07$0.02

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR